4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-18-014731
Options or other derivatives
- Chief Medical Officer acquired 180,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ho Carole Chief Medical Officer | 2018-02-26 | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | D | ||
Loading xslF345X03/doc4.xml…